Subscriber Login

Forgotten your password?



Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Pharmacotherapy for Autism Spectrum Disorders 

Pharmacotherapy for Autism Spectrum Disorders

James T. McCracken


Children, adolescents, and adults with the full range of the autism spectrum disorders (ASDs) are frequently referred for possible pharmacologic treatment for an array of associated difficult-to-manage behaviors, and to support adaptation and progress from other forms of interventions. This chapter reviews the available evidence for each of the major drug classes, as well as information regarding their safety and optimal use. It discusses current recommendations based on the best evidence available for the largest and most commonly presented targets for treatment in individuals with ASDs. Finally, it describes future directions for drug development in ASDs based on emerging models of etio-pathophysiology of ASDs and related conditions.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.